Zhanyi Zhou
Hangzhou, 310051, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Peoniflorin Alleviates Corticotropin-Releasing Factor-Induced Irritable Bowel Syndrome by Improving the Intestinal Barrier Function through the Inhibition of the CRFR1/ROCK2/MLC Signaling Pathway.
Journal: Journal of agricultural and food chemistry
Published: January 19, 2026
Letter to the editor regarding: 'characteristic analysis of early gastric cancer after Helicobacter pylori eradication: a multicenter retrospective propensity score-matched study'.
Journal: Annals of medicine
Published: August 25, 2025
Letter to the Editor: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study.
Journal: Epidemiology and health
Published: August 12, 2025
Meta-analysis of yoga-based mind-body interventions in the management of inflammatory bowel disease.
Meta-analysis of yoga-based mind-body interventions in the management of inflammatory bowel disease.
Journal: Complementary therapies in medicine
Published: August 09, 2025
Therapeutic Targeting of PPARγ in Nonalcoholic Fatty Liver Disease: Efficacy, Safety, and Drug Development.
Journal: Drug design, development and therapy
Published: February 26, 2025
Inflammatory burden index (IBI) and body roundness index (BRI) in gallstone risk prediction: insights from NHANES 2017-2020.
Journal: Lipids in health and disease
Published: January 03, 2025
Oxymatrine for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis.
Journal: Frontiers in medicine
Published: December 10, 2024
Biomimetic rhCOL17-P334 Conjugate for Enhanced Wound Healing.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: November 19, 2024
Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: April 03, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026